Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Biotangents

Biotangents
2015 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
6 INVESTORS
Description

Provider of synthetic biology related research and devleopment services intended to offer an advanced method of assembling DNA parts into a pre-defined order as part of a single reaction. The company's synthetic biology related research and devleopment services is designed for engineering the metabolism of bacteria to produce large quantities of useful compounds, originally high value fragrance molecules, enabling its clients to receive a service to design, manipulate and assemble genetic constructs.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • Pentlands Science Park
  • Bush Loan
  • Penicuik EH26 0PZ
  • Scotland

+44 0131 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Biotangents’s full profile, request a free trial.

Biotangents Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 04-Dec-2017 00000 Completed Generating Revenue
4. Early Stage VC 01-Dec-2017 00000 00000 Completed Generating Revenue
3. Early Stage VC 00000 00000 Completed Generating Revenue
2. Accelerator/Incubator 27-Feb-2017 Completed Generating Revenue
1. Grant 01-Jan-2016 $67.8K Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Biotangents Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Department for International Development Limited Partner 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Kelvin Capital Venture Capital Minority 000 0000 000000 0
Bio-start Accelerator/Incubator Minority 000 0000 000000 0
SynbiCITE Other 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Biotangents Executive Team (3)

Name Title Board
Seat
Contact
Info
Alan Hale Chief Executive Officer
Andy Hall-Ponselè Co-Founder & Lead Scientist
Lina Gasiūnaitė Co-Founder & Lead Scientist